Abstract:
There are many challenges that face radionuclide production and application for medical diagnostics and therapy in Russia. In this article, the development of novel production methods for medical radionuclides ($^{82}$Sr, $^{82}$Sr/$^{82}$Rb-generator, $^{117 \rm m}$Sn, $^{225}$Ac, etc.) at the Institute for Nuclear Research, RAS is described, providing an example of how supporting basic nuclear facilities, backing fundamental research, granting scientists and medical specialists freedom in choosing a research area, and effective international collaboration involving developed countries combine to enable progress in the field.
Keywords:radioisotopes, linear proton accelerator, Russia, nuclear medicine, applied research, international collaboration, strontium-82, tin-117m, actinium-225.
PACS:28.65.+a, 87.53.-j, 87.56.-v
Received:January 10, 2016 Accepted: December 7, 2015